SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-17-007534
Filing Date
2017-08-14
Accepted
2017-08-14 16:02:34
Documents
4
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT kbph_10q.htm 10-Q 300269
2 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF kbph_ex311.htm EX-31.1 18661
3 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF kbph_ex312.htm EX-31.2 18325
4 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE kbph_ex321.htm EX-32.1 9918
  Complete submission text file 0001654954-17-007534.txt   348300
Mailing Address 500 AUSTRALIAN AVENUE S. SUITE 600 WEST PALM BEACH FL 33401
Business Address 500 AUSTRALIAN AVENUE S. SUITE 600 WEST PALM BEACH FL 33401 416-955-0159
KYTO BIOPHARMA INC (Filer) CIK: 0001164888 (see all company filings)

IRS No.: 651086538 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50390 | Film No.: 171030010
SIC: 2834 Pharmaceutical Preparations